CSIMarket


Rocket Pharmaceuticals Inc   (RCKT)
Other Ticker:  
 


 

Rocket Pharmaceuticals Inc

RCKT's Financial Statements and Analysis



Rocket Pharmaceuticals Inc narrowed third quarter of 2023 net loss per share of $-0.75 compare to net loss per share of $-0.87 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.82 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ -0.75 $  0 Mill
$+0.12     Unch.    



Rocket Pharmaceuticals Inc 's Revenue fell by 0 % in third quarter of 2023 (Sep 30 2023) year on year, to $0 million and declined by sequentially.


Rocket Pharmaceuticals Inc is

More on RCKT's Income Statement



Rocket Pharmaceuticals Inc 's in thethird quarter of 2023 recorded net loss of $-61.899 million, an increase from net loss of $-57.756 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-65.701 million realized in previous quarter.

More on RCKT's Growth

Rocket Pharmaceuticals Inc Inventories
RCKT's Cash flow In the third quarter of 2023 company's net cash flow was $181 million, capital expenditures fell by -0.503825.45%, to $-5 millions compare to same quarter a year ago

More on RCKT's Cash flow Statement


Rocket Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Rocket Pharmaceuticals Inc payed $ -2.68 cash per share, on a free-cash flow basis .

Book value grew by 30.76 % sequentially to $6.55 per share.
Tangible Book value grew to $ 5.77 per share from $ 4.20.

Company issued 2.16 million shares or 2.69 % in Sep 30 2023.


More on RCKT's Dividends

 Market Capitalization (Millions) 2,215
 Shares Outstanding (Millions) 83
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -253
 Cash Flow (TTM) (Millions $) 29
 Capital Exp. (TTM) (Millions $) -15
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 143




Rocket Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Rocket Pharmaceuticals Inc had negative $ -2.68 cash flow per share, on a free-cash flow basis .

Book value grew by 30.76 % sequentially to $6.55 per share.
Tangible Book value grew to $ 5.77 per share from $ 4.20.

Company issued 2.16 million shares or 2.69 % in Sep 30 2023.


More on RCKT's Balance Sheets

 Market Capitalization (Millions) 2,215
 Shares Outstanding (Millions) 83
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -253
 Cash Flow (TTM) (Millions $) 29
 Capital Exp. (TTM) (Millions $) -15
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 143
   


  News about Rocket Pharmaceuticals Inc Earnings

Rocket Pharmaceuticals Inc. Faces Operating Shortfall Increase in Q3 2023 Earnings Season

Ro...

Rocket Pharmaceuticals Inc Faces Operating Deficit of $-68.757 Million in Q2 2023: A Closer Look at its Impact on the Company's Shares

As an avid reader of the Wall Street Journal, I would like to offer my interpretation of the recent financial results of Rocket Pharmaceuticals Inc and their impact on the ...

Rocket Pharmaceuticals Inc.: A Challenging Fiscal Year Evidences Concerns for Investors

Investing in the stock market can be risky, and it's crucial to do your research before making any decisions. Rocket Pharmaceuticals Inc has recorded a cumulative net loss of $-237 million over the last 12 months, resulting in a negative return on equity. This is not a promising sign for potential investors.
Additionally, there are 56 other companies within the Major Pharmaceutical Preparations industry that have a higher return on equity than Rocket Pharmaceuticals Inc. The company's total ranking has also deteriorated compared to the previous quarter. These factors indicate that the company may not be performing as well as other...


Date modified: 2023-11-08T18:20:41+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com